Cellevolve Bio Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study Evaluating JCPyV-specific T Cell Therapy for PML (NCT05541549) | Cellevolve Bio Inc | 2023-02-01 |
Track Cellevolve Bio Inc automatically
Every clearance here is in the API, with alerts when new ones post.